Header

UZH-Logo

Maintenance Infos

N-(1,3-Dimethylbutyl)-N′-phenyl-p-phenylenediamine (6-PPD) [MAK Value Documentation, 2013]


Hartwig, A; MAK Commission; et al; Arand, Michael (2016). N-(1,3-Dimethylbutyl)-N′-phenyl-p-phenylenediamine (6-PPD) [MAK Value Documentation, 2013]. The MAK Collection for Occupational Health and Safety, 1(2):746-770.

Abstract

The German Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area has evaluated the maximum concentration at the workplace (MAK value) of N‐(1,3‐dimethylbutyl)‐N′‐phenyl‐p‐phenylenediamine, considering all toxicity endpoints. Available unpublished study reports and publications are described in detail. Critical effects of N‐(1,3‐dimethylbutyl)‐N′‐phenyl‐p‐phenylenediamine are increased liver weights, changes in haematological parameters with mild anaemia after higher doses and its skin‐sensitizing property. The chronic NOAEL in male rats is 2.6 mg/kg body weight based on effects on the liver which can be used to calculate a MAK value of 2 mg/m3 for the inhalable fraction. This value also provides protection from irritation. As the critical effect is systemic, Peak Limitation Category II is assigned. The default excursion factor of 2 is set as no half‐life in blood is known. Damage to the embryo is unlikely if the MAK value for N‐(1,3‐dimethylbutyl)‐N′‐phenyl‐p‐phenylenediamine is observed and the substance is classified in Pregnancy Risk Group C. N‐(1,3‐dimethylbutyl)‐N′‐phenyl‐p‐phenylenediamine is a skin sensitizer and the designation with “Sh” is assigned. There are no data concerning the potential for respiratory sensitization. Skin contact is not expected to contribute significantly to systemic toxicity. N‐(1,3‐dimethylbutyl)‐N′‐phenyl‐p‐phenylenediamine is not genotoxic or carcinogenic.

Abstract

The German Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area has evaluated the maximum concentration at the workplace (MAK value) of N‐(1,3‐dimethylbutyl)‐N′‐phenyl‐p‐phenylenediamine, considering all toxicity endpoints. Available unpublished study reports and publications are described in detail. Critical effects of N‐(1,3‐dimethylbutyl)‐N′‐phenyl‐p‐phenylenediamine are increased liver weights, changes in haematological parameters with mild anaemia after higher doses and its skin‐sensitizing property. The chronic NOAEL in male rats is 2.6 mg/kg body weight based on effects on the liver which can be used to calculate a MAK value of 2 mg/m3 for the inhalable fraction. This value also provides protection from irritation. As the critical effect is systemic, Peak Limitation Category II is assigned. The default excursion factor of 2 is set as no half‐life in blood is known. Damage to the embryo is unlikely if the MAK value for N‐(1,3‐dimethylbutyl)‐N′‐phenyl‐p‐phenylenediamine is observed and the substance is classified in Pregnancy Risk Group C. N‐(1,3‐dimethylbutyl)‐N′‐phenyl‐p‐phenylenediamine is a skin sensitizer and the designation with “Sh” is assigned. There are no data concerning the potential for respiratory sensitization. Skin contact is not expected to contribute significantly to systemic toxicity. N‐(1,3‐dimethylbutyl)‐N′‐phenyl‐p‐phenylenediamine is not genotoxic or carcinogenic.

Statistics

Citations

Dimensions.ai Metrics

Altmetrics

Additional indexing

Item Type:Journal Article, not_refereed, original work
Communities & Collections:04 Faculty of Medicine > Institute of Pharmacology and Toxicology
07 Faculty of Science > Institute of Pharmacology and Toxicology
Dewey Decimal Classification:570 Life sciences; biology
610 Medicine & health
Language:English
Date:27 April 2016
Deposited On:17 Oct 2019 12:49
Last Modified:17 Oct 2019 12:51
Publisher:Wiley-VCH Verlag
ISSN:2509-2383
ISBN:9783527600410
OA Status:Closed
Publisher DOI:https://doi.org/10.1002/3527600418.mb79324e5516

Download

Full text not available from this repository.
View at publisher

Get full-text in a library